Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Monserrat Iglesias

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Cardiology Reports|August 22, 2022
Genetic Testing as a Guide for Treatment in Dilated CardiomyopathiesSoledad García-Hernandez, Lorenzo Monserrat Iglesias
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 6, 2020
Development and validation of a next-generation sequencing panel for clinical pharmacogeneticsLuis Ramudo-Cela, Jesús María López-Martí, Daniel Colmeiro-Echeberría, et al.
Revista Espanola De Cardiologia|January 29, 2003
[Exercise echocardiography to differentiate dilated cardiomyopathy from ischemic left ventricular dysfunction]Jesús Peteiro Vázquez, Lorenzo Monserrat Iglesias, Eugenia Vázquez Rey, et al.
International Journal of Cardiology|June 15, 2010
The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humansTomás Ripoll Vera, Lorenzo Monserrat Iglesias, Manuel Hermida Prieto, et al.
The Pharmacogenomics Journal|April 1, 2022
Combining familial hypercholesterolemia and statin genetic studies as a strategy for the implementation of pharmacogenomics. A multidisciplinary approachLuis Ramudo-Cela, Sara Santana-Martínez, Maite García-Ramos, et al.
Revista Espanola De Cardiologia (English Ed.)|March 1, 2021
Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variantArsonval Lamounier Junior, Alba Guitián González, Alejandro Rodríguez Vilela, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Cardiology Reports|August 22, 2022
Genetic Testing as a Guide for Treatment in Dilated CardiomyopathiesSoledad García-Hernandez, Lorenzo Monserrat Iglesias
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 6, 2020
Development and validation of a next-generation sequencing panel for clinical pharmacogeneticsLuis Ramudo-Cela, Jesús María López-Martí, Daniel Colmeiro-Echeberría, et al.
Revista Espanola De Cardiologia|January 29, 2003
[Exercise echocardiography to differentiate dilated cardiomyopathy from ischemic left ventricular dysfunction]Jesús Peteiro Vázquez, Lorenzo Monserrat Iglesias, Eugenia Vázquez Rey, et al.
International Journal of Cardiology|June 15, 2010
The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humansTomás Ripoll Vera, Lorenzo Monserrat Iglesias, Manuel Hermida Prieto, et al.
The Pharmacogenomics Journal|April 1, 2022
Combining familial hypercholesterolemia and statin genetic studies as a strategy for the implementation of pharmacogenomics. A multidisciplinary approachLuis Ramudo-Cela, Sara Santana-Martínez, Maite García-Ramos, et al.
Revista Espanola De Cardiologia (English Ed.)|March 1, 2021
Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variantArsonval Lamounier Junior, Alba Guitián González, Alejandro Rodríguez Vilela, et al.
Pageof 1